CClinicalTrials.gg
Sign In
WithdrawnNCT02150382Updated Jul 29, 2022

China Rural Hypertension Control Project 2014

An observational study in Hypertension, sponsored by First Hospital of China Medical University. Withdrawn at 1 site in China. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2022-07-29.

Sponsored by First Hospital of China Medical University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
40 Years and older
Sex
All
01

Study summary

China Rural Hypertension Control (CRHC) Project is a cluster randomized trial aims to test the effectiveness of a standardized protocol-based treatment program on hypertension control in rural China.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • hypertension
  • rural
  • China
  • protocol-based treatment
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

Browse Hypertension studies →

Lead sponsor

First Hospital of China Medical University is the lead sponsor of 59 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All study patients will be recruited from rural areas in Liaoyang County from blood pressure screening. Liaoyang County, Liaoning Province is located in Northeast China.

Inclusion criteria

  • Man and women aged 40 years or older.
  • Mean systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg; and/or use of antihypertensive medications.Mean blood pressure is based on three measurements at two separate days at least two days apart and within one month.
  • Permanent residents in the study villages.
  • Do not plan to emigrate in the next 2 years.

Exclusion criteria

Exclusion Criteria:

  • Unable to provide consent.
  • Treated for malignant tumor and life expectancy\<2 years judged by study physician.
  • Pregnancy, currently trying to become pregnant, or of child-bearing potential and not using birth control.
  • Diagnosted psychiatric patients.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. a composite outcome of cardiovascular disease and all-cause mortality

    Time frame: up to 2-year

Secondary outcomes

  1. Major cardiovascular diseases

    Time frame: up to 2-year

  2. Fatal and non-fatal stroke

    Time frame: up to 2-year

  3. Fatal and non-fatal myocardial infarction

    Time frame: up to 2-year

  4. Hospitalized or treated heart failure

    Time frame: up to 2-year

  5. Cardiovascular death

    Time frame: up to 2-year

  6. Change in mean systolic and diastolic blood pressure

    Time frame: up to 2-year

  7. Proportion of hypertension control

    Time frame: up to 2-year

07

Study locations

1 site
  • First Hospital of China Medical University
    Shenyang, Liaoning 110001, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02150382
Lead sponsor
First Hospital of China Medical University
Responsible party
Yingxian Sun (Chief of Department of Cardiology in First Hospital of China Medical University, First Hospital of China Medical University) — Principal investigator
First posted
May 29, 2014
Start date
Feb 2014
Primary completion
Jul 2016 (estimated)
Completion
Oct 2016 (estimated)
Last update
Jul 29, 2022
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypertension→

Other studies from this sponsor

First Hospital of China Medical University

Start the discussion